Atherectomy Devices Market Size By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices), By Application (Peripheral Vascular Application, Coronary Application), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Industry Trends

Atherectomy Devices Market size valued at USD 525 million in 2020 and is projected to grow at around 9.5% CAGR from 2021 to 2027. These devices are used to debulk lesions as well as vessel preparation in coronary or peripheral arteries before stenting or angioplasty. This facilitates proper functioning of vessels, thereby minimizing the risk of cardiac arrest or ischemia. The devices are high in demand pertaining to growing trend of minimally invasive surgeries as they offer minimal damage to the body, as compared to conventional medical surgeries.
 

To get more details on this report: Request Free Sample PDF
 

Minimally invasive procedures are associated with shorter stay in hospital as well as reduced risk of complications. There has been a significant rise in the prevalence of coronary and peripheral atrial diseases, which is fueling the demand for vascular devices.
 

The emergence of COVID-19 pandemic at a global level is an unprecedented health concern and has adversely impacted the atherectomy devices market. The sudden outbreak of SARS-CoV-2 has shutdown vast portions of global economy and supply chain disruptions, setting restrictions on trade and movement of goods, impacting the industry growth. COVID-19 has affected the industry by financial adversities on the firms and by impacting production and demand.
 

However, there has been a gradual rise in demand for these devices amidst the pandemic due to reduction in patients suffering from SARS-CoV-2 virus in some economies along with implementation of standard operating guidelines. These factors would further foster the demand in hospitals and ambulatory surgical centers. As a result, the adverse impact of the pandemic will gradually reduce as the demand for these device systems is rising.
 

Increasing prevalence of peripheral arterial diseases will drive the market growth

The prevalence of peripheral arterial diseases (PAD) has been on rise. As per a published report, 2 million Americans are affected by PAD, propelling the demand for atherectomy devices. As per the National Health and Nutrition Examination Survey studies, around 6% of people aged above 40 years that equates to approximately 7 million patients in the U.S. alone and about 200 million globally are currently suffering from PAD. Other factors such as cigarette smoking, diabetes, and hypertension are also contributing to the growing prevalence of PAD.
 

These systems have emerged as a crucial therapy in peripheral artery disease (PAD) management as it reduces plaque burden using an adjunctive endovascular procedure in patients suffering from PAD. The devices offer various benefits including minimized risk of complication and relatively enhanced comfort during surgical procedures over traditional procedures. Thus, these devices are increasingly being used in PAD care.
 

Recent technological advancements to stimulate the atherectomy devices market expansion

Advancements in endovascular technologies have facilitated minimally invasive percutaneous approach in the management of peripheral and coronary vascular diseases in majority of patients on the conventional invasive approach. Current developments are majorly in the fields of revascularization approaches, non-invasive imaging, and prevention of cerebrovascular as well as cardiac complications by the means of aggressive risk factor management that has reduced the need for invasive surgeries.
 

Technologically advanced devices have emphasized on non-invasive debulking of the plaque and enhancing safety. For instance, in April 2019, Avinger Inc. received premarketing approval (PMA) for its Pantheris lumivascular atherectomy system, an improvised version of atherectomy system used in the management of PAD. This atherectomy system is a premier intravascular image-guided system that aids healthcare professionals by providing visuals within the artery, implementing optical coherence tomography (OCT) technique.
 

Increase in adoption of laser atherectomy devices will augment the market outlook

Laser product segment held significant atherectomy devices market revenue share accounting for more than 27% in 2020. Multiple advantages over mechanical systems that include versatility, better operability and eliminates the requirement of embolic protection device is likely to fuel the market revenue.
 

Additionally, laser integrated atherectomy devices use monochromatic light beam with high energy, to eliminate thrombi; to dissolve procoagulant reactants along with debulking of the underlying plaque without harming the surrounding tissue. Furthermore, these laser atherectomy devices offer high precision with advances in technology coupled with reduced recovery time and stay in the hospital.
 

Rising peripheral vascular ailments to increase the demand of atherectomy devices market

Periphery vascular applications segment accounted for majority market share in 2020 with around USD 411 million in valuation. The majority share of the segment is driven by growing number of patients suffering from peripheral vascular diseases, rising geriatric population and lethargic lifestyle of the people. The atherectomy devices used in peripheral vascular applications are beneficial on account of the highly precise mechanism and effective management with minimal damage to the surrounding tissues. Moreover, these devices are effective and dependable, thereby increasing preference and adoption. Thus, these devices are highly recommended in treatment of peripheral vascular diseases.
 

Growing demand for atherectomy devices in hospitals will enhance the business growth

To get more details on this report: Request Free Sample PDF
 

Hospitals segment is predicted to capture majority of the atherectomy devices market share in 2020 propelled by high adoption of advanced devices providing enhanced vascular care. Increasing admissions owing to growing cases of peripheral and coronary atrial diseases, shorter stay in the hospitals and availability of highly trained healthcare professionals will boost the demand for atherectomy devices. As a result, well-equipped healthcare settings such as hospitals will be preferred by the patients. Additionally, increasing patient inflow has elevated the product adoption rate.
 

Well-developed healthcare infrastructure in North America region

To get more details on this report: Request Free Sample PDF
 

U.S. atherectomy devices market is anticipated to expand at more than 8.5% CAGR through 2027 impelled by several factors including favorable reimbursement scenario, growing adoption of atherectomy systems by healthcare professionals, and rising prevalence of coronary and peripheral diseases in the country.
 

Germany dominated the European market in 2020 with above USD 19 million revenue. Strong presence of major players emphasizing on innovation, and well-developed infrastructure in the country is driving the industry growth. Growing prevalence of heart-related diseases in the country and rising number of hospitalizations are contributing to the increasing demand for these devices in the country. However, approvals for the atherectomy devices in the region are leading to huge demand.
 

Strategic initiatives implemented by major market players will foster the market share

Some of the major players operating in the atherectomy devices market are Avinger, Medtronic, Cardiovascular Systems, Inc. (CSI), and Koninklijke Philips N.V. among others. Companies are focusing on strategic mergers, acquisitions and partnerships in order to expand their geographical presence and launch new products to strengthen the product portfolio. Furthermore, these players are making investments that enable these players to capture maximum revenue share.
 

Recent industry developments:

• In January 2021, Cardiovascular Systems, Inc. received CE Mark for Diamondback 360 Coronary Orbital Atherectomy System (OAS). The product features GlideAssist that permits tracking and easier repositioning and removal of device, especially during challenging procedures and can be utilized in treating various calcium modalities. The strategic move will assist the company in expanding its product portfolio.
  
   
• In March 2020, Straub Medical announced the launch of Roterex S atherectomy device in the U.S. The device enables removal of atheroma as well as thrombus simultaneously. The strategic launch aided the company in strengthening their product portfolio and expanding their customer base in the U.S.
   

This market research report on atherectomy devices includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Click here to Buy Section of this Report

Market, By Product, 2016 - 2027 (USD Million)

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Laser Atherectomy Devices
• Rotational Atherectomy Devices

Market, By Application, 2016 - 2027 (USD Million)

• Peripheral Vascular Applications
• Coronary Applications

Market, By End-Use, 2016 - 2027 (USD Million)

• Hospitals
• Ambulatory Surgical Centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE